TUESDAY, Oct. 25, 2022 (HealthDay News) — New research out of Canada offers some encouraging news amid concerns about the opioid epidemic. Doctors are prescribing a lower dose of the painkillers after older adults have surgery, the study found. They are not, however, writing fewer prescriptions for the potentially addictiveContinue Reading
MONDAY, Oct. 24, 2022 (HealthDay News) — For the millions of people who live with vitiligo, a disease that robs the skin of its natural color, a newly approved cream called ruxolitinib (Opzelura) is quickly becoming a game changer. The U.S. Food and Drug Administration approved ruxolitinib for vitiligo inContinue Reading
MONDAY, Oct. 24, 2022 (HealthDay News) — Some Americans could pay up to $130 to get a COVID-19 vaccine made by Pfizer starting in 2023, but most will still get it for free. A Pfizer executive noted that people who would get its vaccine for free would likely include thoseContinue Reading
MONDAY, Oct. 24, 2022 (HealthDay News) — Getting into prescription or over-the-counter medicines at home is a major source of accidental poisoning for young children. Yet, nearly half of parents say they have leftover prescriptions at home, a new poll shows. “We found that it’s common for parents to keepContinue Reading
FRIDAY, Oct. 21, 2022 (HealthDay News) — New government data shows that the chickenpox vaccine has virtually eliminated deaths and severe cases of the virus in U.S. children and teens. In the analysis, released Thursday by the U.S. Centers for Disease Control and Prevention, there were 97% fewer chickenpox casesContinue Reading
FRIDAY, Oct. 21, 2022 (HealthDay News) – In an unanimous vote on Thursday, a panel of U.S. vaccine experts recommended that COVID shots be added to the list of recommended vaccinations for children and adults. Now it’s up to the U.S. Centers of Disease Control and Prevention to decide whetherContinue Reading
THURSDAY, Oct. 20, 2022 (HealthDay News) – Americans will now have another choice if they want a COVID booster shot. On Wednesday, the U.S. Food and Drug Administration approved Novavax Inc.’s protein-based vaccine as a first booster dose. Until now, it had only been approved as a two-dose primary series.Continue Reading
THURSDAY, Oct. 20, 2022 (HealthDay News) — A study testing drugs that are used for other conditions for their potential in treating COVID-19 has found that the antidepressant fluvoxamine (brand name Luvox) offered no benefit, at least at an initial smaller dose. Study participants took 50 mg of the medicationContinue Reading
THURSDAY, Oct. 20, 2022 (HealthDay News) – Just a few years ago, “Friends” actor Matthew Perry almost died from opioid overuse that nearly destroyed his colon and almost killed him. Now, he’s sober and wants to tell his story. Perry has written a memoir, “Friends, Lovers and the Big TerribleContinue Reading
TUESDAY, Oct. 18, 2022 (HealthDay News) — The federal government is pumping millions more dollars into an effort to expand the United States’ network of community mental health centers. Up to 15 states now can apply for $1 million grants to help plan new Certified Community Behavioral Health Clinics (CCBHC)Continue Reading